Exercise and medication for weight loss in women
Part of Hormones & metabolism clinical trials.
This study tests whether adding resistance exercise to a new weight-loss medication helps women preserve muscle while losing weight. It may be an option for women who want to protect their muscle mass during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 50 years old.
- Your body mass index (BMI) is 27 or higher with a weight-related health issue, or between 30 and 35.
- You have not taken GLP-1 medications before (like Wegovy, Ozempic, or Mounjaro).
- You do not have diabetes (type 1 or 2).
- You are not pregnant, planning pregnancy in the next 6 months, or on hormone replacement therapy.
- You have not done regular resistance training (more than 10 sessions per year) before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining a weight-loss medication called tirzepatide (also known as Mounjaro) with a supervised exercise program helps people lose weight and improve their overall health. You'll be in the study for about four months, and you'll get support and monitoring.
This study tests a 12-week digital strength training program for women aged 40–54 who have recently started taking a GLP-1 medication for weight management. The program uses a smartphone app to guide bodyweight exercises at home, with the goal of preserving muscle while losing weight.
This study tests whether a 12-week program of exercise and personalized nutrition can help adults who are obese and taking GLP-1 weight-loss medications maintain muscle and bone while losing fat. It aims to improve strength, fitness, and overall function during treatment.
This study looks at what happens to your body (especially muscle) when you take a newer weight-loss medication, either with or without adding an exercise program. It could help you understand how to best protect your muscle while losing weight.
This study tests whether tirzepatide, a medication that helps with weight loss and blood sugar control, can improve the ability to exercise and daily function in people who have heart failure with reduced pumping strength and are overweight or obese.
This study tests whether a type 2 diabetes medication (tirzepatide) combined with a supervised resistance training (weight lifting) program helps prevent muscle loss while losing weight. You will either receive the medication or a placebo, and all participants will follow a diet and exercise plan.
Hear when a new Muscle Mass and Strength trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.